Cataflam D, Cataflam Sachets 50 mg Dispersible tablets, powder for oral solution
PDF Leaflet Revision Date: 20 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term symptomatic relief for various acute conditions.
Dosage (summary)
Adults: 100-150 mg daily, max 150 mg. Migraine: 50 mg at onset, may repeat after 2 hours.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Lithium
- Digoxin
- Diuretics
- Anticoagulants
- SSRIs
Contraindications
- Gastric ulcer
- Hypersensitivity
- Asthma
- Porphyria
- Heart failure
Common side effects
- Headache
- Dizziness
- Nausea
- Gastrointestinal bleeding
- Rash
Counselling Points
- Take with water on an empty stomach
- Monitor for GI symptoms
- Avoid in pregnancy
Serious warnings
- Gastrointestinal bleeding
- Serious skin reactions
- Cardiovascular events
Important Disclaimer
The Cataflam D, Cataflam Sachets 50 mg Dispersible tablets, powder for oral solution professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
